Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Cava Group (CAVA) Registers a Bigger Fall Than the Market: Important Facts to Note

Cava Group (CAVA) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading day saw Cava Group (CAVA) settling at $62.23, representing a -5.95% change from its previous close.

İlgili Semboller 1
CAVA CAVA
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: PRNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

İlgili Semboller 1
PRCT PRCT
Kaynak: PRNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.28 per share a year ago.

İlgili Semboller 1
TXG TXG
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

İlgili Semboller 1
QDEL QDEL
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.64 per share a year ago.

İlgili Semboller 1
GEN GEN
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago.

İlgili Semboller 1
HALO HALO
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.55 per share a year ago.

İlgili Semboller 1
JANX JANX
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.03 per share a year ago.

İlgili Semboller 1
ABNB ABNB
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $0.34 per share a year ago.

İlgili Semboller 1
ARCT ARCT
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.36 per share a year ago.

İlgili Semboller 1
DOCS DOCS
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.34 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

İlgili Semboller 1
TTD TTD
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap